Quantcast

Latest Cancer immunotherapy Stories

2012-07-16 10:14:45

Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses. To counter that effect, some cancer treatments try to neutralize the cancer's chemical arsenal and boost a patient's immune response--though attempts to do both at the same time are rarely successful. Now, researchers have developed a novel system to simultaneously deliver a sustained dose of both an immune-system booster and a chemical to counter the cancer's secretions,...

2012-06-04 19:20:21

Agent benefits melanoma and lung cancer as well An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center. The results of an expanded Phase 1 trial presented at the American Society of Clinical Oncology's annual conference in Chicago, showed that some patients treated with a fully human monoclonal antibody developed by...

New Cancer Drug Targets Tumor Cells, Reduces Side Effects
2012-06-04 02:57:24

A clinical trial of an experimental new breast cancer treatment found that it extended the life expectancy of patients without the symptoms of the disease worsening, various media outlets reported on Sunday. The drug, TDM-1, is manufactured by Roche, and according to Naomi Kresge and Robert Langreth of Bloomberg, it works by carrying chemotherapy directly into cancer cells while successfully avoiding healthy ones, resulting in fewer side effects than conventional treatments. According...

2012-06-02 23:01:47

• Clinical Activity of Anti-PD-1 Published in New England Journal of Medicine (NEJM) and Presented at 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) • Phase 1 Data on Second Investigational Immunotherapy (Anti-PD-L1) Also Published in NEJM and Presented at ASCO Milwaukee, WI (PRWEB) June 02, 2012 SITC leaders publish landmark studies of new cancer immunotherapeutics Clinical activity of two cancer immunotherapeutic agents, anti-PD-1 and anti-PD-L1 were...

2012-05-31 01:24:04

TAU researcher develops new antibodies to target and destroy cancer cells Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price – many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body. Prof. Daniel Wreschner of Tel Aviv...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related